Literature DB >> 7798654

Effects of endotoxin in the lungs of neonatal rats: age-dependent impairment of the inflammatory response.

T R Martin1, J T Ruzinski, C B Wilson, S J Skerrett.   

Abstract

Age-dependent maturation of the intrapulmonary inflammatory responses to bacterial lipopolysaccharide (LPS) was studied because nosocomial gram-negative infections cause morbidity in newborn infants. Escherichia coli LPS or live E. coli were injected into the airways of neonatal or adult rats; intrapulmonary recruitment of leukocytes was measured 6 h later. Neonates showed age- and dose-dependent impairment of intrapulmonary neutrophil recruitment after intratracheal administration of LPS or live E. coli that persisted for the first 28 days of life. Neonatal and adult alveolar macrophages released similar amounts of neutrophil chemotactic activity and tumor necrosis factor in response to incubation with LPS in vitro. Treatment of neonates with intratracheal or systemic interferon-gamma did not augment the response to LPS. Thus, intrapulmonary inflammatory responses to LPS and gram-negative bacteria are impaired early in life and do not approach adult levels until approximately 4 weeks of age.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7798654     DOI: 10.1093/infdis/171.1.134

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells.

Authors:  Ofer Levy; Eugénie E Suter; Richard L Miller; Michael R Wessels
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

2.  Effects of age on the synergistic interactions between lipopolysaccharide and mechanical ventilation in mice.

Authors:  Lincoln S Smith; Sina A Gharib; Charles W Frevert; Thomas R Martin
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-09       Impact factor: 6.914

3.  Immune response to intrapharyngeal LPS in neonatal and juvenile mice.

Authors:  Sharon A McGrath-Morrow; Seakwoo Lee; Kevin Gibbs; Armando Lopez; Joseph M Collaco; Enid Neptune; Mark J Soloski; Alan Scott; Franco D'Alessio
Journal:  Am J Respir Cell Mol Biol       Date:  2015-03       Impact factor: 6.914

4.  Lipopolysaccharide-induced injury is more pronounced in fetal transgenic ErbB4-deleted lungs.

Authors:  Andreas Schmiedl; Jan Behrens; Katja Zscheppang; Erkhembulgan Purevdorj; Dietlinde von Mayersbach; Andrea Liese; Christiane E L Dammann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-01       Impact factor: 5.464

5.  The innate immune response to lower respiratory tract E. Coli infection and the role of the CCL2-CCR2 axis in neonatal mice.

Authors:  Sharon A McGrath-Morrow; Roland Ndeh; Joseph M Collaco; Amy K Poupore; Dustin Dikeman; Qiong Zhong; Benjamin D Singer; Franco D'Alessio; Alan Scott
Journal:  Cytokine       Date:  2017-06-16       Impact factor: 3.861

6.  The importance of neutrophils in resistance to pneumococcal pneumonia in adult and neonatal mice.

Authors:  B A Garvy; A G Harmsen
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

7.  Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome.

Authors:  W B Klimstra; K D Ryman; K A Bernard; K B Nguyen; C A Biron; R E Johnston
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 8.  Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia.

Authors:  Vineet Bhandari
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-02-27

9.  Functional immaturity of rat alveolar macrophages during postnatal development.

Authors:  J M Bakker; E Broug-Holub; H Kroes; E P van Rees; G Kraal; J F van Iwaarden
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

10.  Endotoxin inhalation alters lung development in neonatal mice.

Authors:  Katarina Kulhankova; Caroline L S George; Joel N Kline; Melissa Darling; Peter S Thorne
Journal:  Am J Ind Med       Date:  2012-05-10       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.